Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|5|613-619

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.5, 2016-12, pp. : 613-619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections

By  

Current Pharmaceutical Design, Vol. 21, Iss. 28, 2015-08 ,pp. : 4106-4111

Bentham Science Publishers

Access to resources Recommend Favorite

Development and Clinical Application of Peptide-Based Radiopharmaceuticals

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2951-2963

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide-Based Nanoparticle for Ex Vivo and In Vivo Dug Delivery

By  

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3656-3665

Bentham Science Publishers

Access to resources Recommend Favorite

Is Phage Display Technology on Target for Developing Peptide-Based Cancer Drugs?

By  

Current Drug Discovery Technologies, Vol. 1, Iss. 2, 2004-06 ,pp. : 113-132

Bentham Science Publishers

Access to resources Recommend Favorite

In-vivo Modulation of Gastrointestinal Motility by Cannabinoid Drugs

By Izzo A.A.   Addeo D.   Amato M.   Borrelli F.   Capasso R.   Di Carlo G.   Nocerino E.   Mascolo N.   Pinto L.   Capasso F.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 255-258

Pharmaceutical Press

Access to resources Recommend Favorite